Lacovit Deodorant Antiperspirant Original
Aluminum Chlorohydrate
Ac Marca Personal Care
Human Otc Drug
NDC 42283-032Lacovit Deodorant Antiperspirant Original also known as Aluminum Chlorohydrate is a human otc drug labeled by 'Ac Marca Personal Care'. National Drug Code (NDC) number for Lacovit Deodorant Antiperspirant Original is 42283-032. This drug is available in dosage form of Kit. The names of the active, medicinal ingredients in Lacovit Deodorant Antiperspirant Original drug includes . The currest status of Lacovit Deodorant Antiperspirant Original drug is Active.
Drug Information:
| Drug NDC: | 42283-032 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | Lacovit Deodorant Antiperspirant Original |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Aluminum Chlorohydrate |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | Ac Marca Personal Care |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Kit |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | |
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | |
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | OTC MONOGRAPH FINAL |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 01 Jan, 2019 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 24 Mar, 2023 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Application Number: | part350 |
| This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null. |
| Listing Expiration Date: | 09 May, 2026 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | AC MARCA PERSONAL CARE
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| Original Packager: | Yes
|
| Whether or not the drug has been repackaged for distribution. |
| UPC: | 8410190574328
8411135353039
|
| UPC stands for Universal Product Code. |
| UNII: | |
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 42283-032-04 | 1 KIT in 1 KIT (42283-032-04) * 1 BOTTLE in 1 BOX (42283-028-50) / 50 mL in 1 BOTTLE | 01 Jan, 2019 | 24 Mar, 2023 | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
Purpose antiperspirant
Purpose antiperspirant
Product Elements:
Lacovit deodorant antiperspirant original aluminum chlorohydrate lactovit original deodorant and antiperspirant aluminum chlorohydrate water steareth-2 ppg-15 stearyl ether steareth-21 butylene glycol hydroxyethyl urea sodium lactate calcium lactate allantoin levomenol triclosan cyclomethicone 5 farnesol ammonium lactate edetate disodium anhydrous phenoxyethanol isomethyl-.alpha.-ionone butylphenyl methylpropional citral .beta.-citronellol, (r)- coumarin geraniol .alpha.-hexylcinnamaldehyde aluminum chlorohydrate aluminum chlorohydrate
Indications and Usage:
Uses: reduces underarm wetness.
Uses reduces underarm wetness.
Warnings:
Warning: for external use only. do not use on broken skin. in case of accidental ingestion seek professional assistance or contact a poison control center immediately. keep away from face and mouth. ask a doctor or pharmacists before use if you have kidney disease. stop use and ask doctor if rash or irritation occurs. keep out of reach of children. if swallowed, get medical help or contact a poison control center right away.
Warning for external use only. do not use on broken skin. in case of accidental ingestion seek professional assistance or contact a poison control center immediately. keep away from face and mouth. ask a doctor or pharmacists before use if you have kidney disease. stop use and ask a doctor if rash or irritation occurs. keep out of reach of children. if swallowed, get medical help or contact a poison control center right away.
Do Not Use:
Warning: for external use only. do not use on broken skin. in case of accidental ingestion seek professional assistance or contact a poison control center immediately. keep away from face and mouth. ask a doctor or pharmacists before use if you have kidney disease. stop use and ask doctor if rash or irritation occurs. keep out of reach of children. if swallowed, get medical help or contact a poison control center right away.
Warning for external use only. do not use on broken skin. in case of accidental ingestion seek professional assistance or contact a poison control center immediately. keep away from face and mouth. ask a doctor or pharmacists before use if you have kidney disease. stop use and ask a doctor if rash or irritation occurs. keep out of reach of children. if swallowed, get medical help or contact a poison control center right away.
Dosage and Administration:
Directions: apply to underarms only.
Directions apply to underarms only.
Stop Use:
Stop use and ask doctor if rash or irritation occurs.
Stop use and ask a doctor if rash or irritation occurs.
Package Label Principal Display Panel:
Package labeling: kit
Drug part
Further Questions:
Questions or comments: + 1-787-780-4043
Questions or comments: + 1-787-780-4043